Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
Presentations
Ethos Discovery Stratified Outcomes for Lymphoma in Dogs (SOLID) Study: Informing Subclassification & Prognosis
ACVIM Forum 2025
Learn More →
Scientific Publications
Identification of novel genetic mutations for the treatment prognostication of canine lymphoma
npj Precision Oncology
Learn More →
Presentations
Chemotherapy selection for advanced or metastatic pancreatic cancer using machine learning models trained with multi-center datasets
2025 ASCO Gastrointestinal Cancers Symposium
Learn More →
Presentations
Optimizing the first line therapy of canine B-cell lymphomas via machine learning
Symposium on Artificial Intelligence in Veterinary Medicine (SAVY) 2.0
Learn More →
In the News
How Artificial Intelligence Is Revolutionising Cancer Care for Pets
Pets Magazine
Learn More →
Video/Podcast Interviews
AI, Cancer & the Future of Pet Care with Dr Ilona Holcomb
The Pets Mag Podcast
Learn More →
Presentations
A study on the relationship between ex vivo drug sensitivity and clinical outcome of acute lymphoblastic leukemia
AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals
Learn More →
In the News
Artificial Intelligence Takes on Cancer: The Only AI Dr. Karyn Doesn’t Hate
Dogster
Learn More →
In the News
Comparative Oncology: Advances in Cancer Care from Pets to Humans
Pharmacy Times
Learn More →
In the News
Cancer Treatment Gets Personal: How Artificial Intelligence Is Taking the Guesswork Out of Common Canine Cancers
Dogster
Learn More →
In the News
Ilona Holcomb on How ImpriMed’s AI is Transforming Cancer Treatment for Pets and Humans
Biopharma Boardroom
Learn More →
Scientific Publications
A study on the relationship between MDR1 mutation and ex vivo drug sensitivities of canine lymphomas
Biotechnology and Bioprocess Engineering
Learn More →
Video/Podcast Interviews
Sit, Stay, and Heal: Bringing Precision Medicine to Dogs, then Humans
The Bio Report
Learn More →
In the News
From Dogs to Humans: AI-Powered Drug Response Prediction Technology Demonstrates Improved Clinical Outcomes in Oncology
Pharmacy Times
Learn More →
Scientific Publications
Recent advances in and applications of ex vivo drug sensitivity analysis for blood cancers
Blood Research
Learn More →
Presentations
Boosting the power of AI-based treatment outcome predictions for canine lymphoma by combining tumor and germline genetic biomarkers and live-cell analytics
Veterinary Cancer Society Annual Conference 2024
Learn More →
Presentations
Decoding Feline Lymphoma: From Diagnosis to Prognosis
Veterinary Cancer Society Annual Conference 2024
Learn More →
Presentations
Novel Genetic Biomarkers of Chemotherapeutic Response in Canine Lymphoma and Improved Predictive Power With Integration of Machine Learning
Veterinary Cancer Society Annual Conference 2024
Learn More →
Previous
Next
Webflow Homepage
Veterinary Precision Medicine
Human Precision Medicine
Ex Vivo CRO Services for Pharma
About Us
Careers
Events
Press
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Contact Us
